Pyrazolotriazinecarbonitriles useful as kinase inhibitors

A compound of Formula (I):

• or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein:
• R1 is independently C1-4 alkyl, C3-4 cycloalkyl substituted with 0-1 R1a;
• R1a is independently F or C1-4 alkyl;
• R2 and R3 are independently Cl, cyano, C1-4 alkoxy, C1-4 fluoroalkoxy, or C3-4 cycloalkyl;
• R4 is independently
• R5 is independently H, C1-4 fluoroalkyl, —C(═O)(C1-4 alkyl), —C(O)(C1-4 fluoroalkyl), —C(═O)C(C1-2 alkyl)(C1-2 fluoroalkyl)(OH), —C(═O)O(C1-4 alkyl), —C(═O)CH2O(C1-2 alkyl), —C(═O)CH2OC(═O)(C1-2 alkyl), —C(═O)NHR10, —C(═O)C(═O)NHR11, —SO2(C1-4 alkyl), C1-4 alkyl substituted with 0-2 Ra, —(CH2)0-1—C3-6 cycloalkyl substituted with 0-2 Rd, —X-(4- to 7-membered heterocyclic ring including 1 to 2 ring heteroatoms which are independently N, N(Rb), O, or S(O)p, and wherein the heterocyclic ring is partially saturated or fully saturated, and is substituted with 0 to 2 Re), or —X-(5-membered heteroaryl wherein from 1 to 4 ring atoms are each independently N, or N(Rb), wherein the heteroaryl is substituted with 0 to 1 Rd);
• X is independently a bond, —CH2—, —C(═O)—, —C(═O)CH2—, —CH2C(═O)—, or —C(═O)O—;
• R6 is independently C1-4 alkyl substituted with 0-1 OH, C1-4 fluoroalkyl, or C3-4 cycloalkyl;
• R7 and R8 are independently H, C1-4 alkyl substituted with 0-2 Re, —C(═O)(C1-4 alkyl), —C(═O)O(C1-4 alkyl), —CH2C(═O)NH2, —SO2(C1-2 alkyl),
• R9 is independently H, C1-4 alkyl substituted with 0-2 Re, —C(═O)(C1-4 alkyl), —C(═O)O(C1-4 alkyl), or;
• R10 is independently C1-4 alkyl substituted with 0-2 Rc, C1-4 fluoroalkyl, or C3-4 cycloalkyl;
• R11 is independently H, C1-4 alkyl, or C3-4 cycloalkyl;
• Ra is independently halogen, OH, C1-4alkoxy, —C(═O)NH2, —C(═O)O(C1-4 alkyl), C3-4 cycloalkyl substituted with 0-1 Rd, or
• Rb is independently H, C1-4 alkyl substituted with 0-2 Re, —C(═O)(C1-4 alkyl), —C(═O)C(C1-2 alkyl)(C1-2 fluoroalkyl)(OH), —C(═O)O(C1-4 alkyl), —C(═O)C(═O)NH2, —SO2(C1-4 alkyl substituted with 0-1 Re), C3-4 cycloalkyl substituted with 0-1 Rd,
• Rc is independently C1-2 alkoxy;
• Rd is independently D, halogen, OH, NH2, C1-4alkyl, or —SO2(C1-4alkyl);
• Re is independently oxo or Rd;
• Rf is independently F, OH, C1-4 alkoxy, or —C(═O)NH2.
• n is independently 0, 1 or 2;
• and
• p is independently 0, 1 or 2.